Cohance Lifesciences Limited (BOM:543064)
India · Delayed Price · Currency is INR 457.05
+10.30 (2.31%)
At close: Oct 6, 2026
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 174.24 billion as of October 7, 2026. Its market cap has decreased by 47.99% in one year.
Market Cap
174.24B
Enterprise Value
176.21B
Revenue
21.42B
Global Rank
n/a
Country Rank
n/a
PE Ratio
164.02
ChartMarket Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 174.24B, an increase of 516,856.55%. That is a compound annual growth rate of 266.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 174.83B | -13.55% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 349.42B |
| Piramal Pharma | 269.40B |
| Cohance Lifesciences | 174.24B |
| Alivus Life Sciences | 168.18B |
| Alembic Pharmaceuticals | 163.89B |
| Eris Lifesciences | 158.97B |
| NATCO Pharma | 145.10B |
| Sudeep Pharma | 132.20B |